Skip to main content

Table 3 Comparison of patients receiving and not receiving metformin, and patients receiving and not receiving sulfonylurea derivatives

From: Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study

 

Metformin treatment

p

Yes

No

Age [years]

66.2 (±8.4)

70.6 (±8.8)

0.001

BMI [kg/m2]

31.0 (±4.9)

29.1 (±4.9)

0.014

 

Sulfonylurea derivatives treatment

p

Yes

No

Age [years]

68.4 ± 9.0

66.1 ± 8.0

0.093

BMI [kg/m2]

29.8 ± 5.0

31.6 ± 4.7

0.025